Thyroid

Featured Article

ATA Guidelines for Managing Subclinical Hypothyroidism During Pregnancy: Update

ATA Guidelines for Managing Subclinical Hypothyroidism During Pregnancy: Update

Updated guidelines include thyroid function testing, iodine nutrition, pregnancy complications, and treatment of thyroid disease during pregnancy and lactation.

Latest

Active Ophthalmopathy Benefits From Teprotumumab Treatment

Active Ophthalmopathy Benefits From Teprotumumab Treatment

Patients given teprotumumab were more likely to experience a response at 24 weeks vs placebo.

USPSTF: No Thyroid Cancer Screening in Asymptomatic Adults

USPSTF: No Thyroid Cancer Screening in Asymptomatic Adults

Thyroid cancer screening in asymptomatic adults was given a D recommendation because of the negative effects of screening outweighing any benefits.

Subclinical Hypothyroidism Increased Risk for Miscarriage

Subclinical Hypothyroidism Increased Risk for Miscarriage

Miscarriage risk before 20 weeks of gestation is higher among women with untreated subclinical hypothyroidism.

Increased Primary Hyperparathyoridism Risk Linked to Weight in Women

Increased Primary Hyperparathyoridism Risk Linked to Weight in Women

Data were collected from the Nurses' Health Study I to examine the relationship between BMI and primary hyperparathyroidism risk.

Health Care Reform Increases Thyroidectomy Rates for Thyroid Cancer

Health Care Reform Increases Thyroidectomy Rates for Thyroid Cancer

Patients with government subsidized or self-pay insurance were less likely to undergo thyroidectomy for thyroid cancer.

Incidence Of, Mortality From Thyroid Cancer Increased in US

Incidence Of, Mortality From Thyroid Cancer Increased in US

Increases in papillary thyroid cancer were most common between 1974 and 2013.

American Thyroid Association Releases Guidelines As Mobile Apps, Pocket Reference Cards

American Thyroid Association Releases Guidelines As Mobile Apps, Pocket Reference Cards

The pocket references and mobile apps will be updated as diagnostic tools and guidelines continue to improve.

FDA: Levothyroxine Liquid Formulation Approved for Hypothyroidism

FDA: Levothyroxine Liquid Formulation Approved for Hypothyroidism

Tirosint-SOL (levothyroxine sodium oral solution) should be available within the next 6 months.

Risk of Pregnancy Loss in Subclinical Hypothyroidism

Risk of Pregnancy Loss in Subclinical Hypothyroidism

Women with subclinical hypothyroidism who undergo thyroid hormone treatment have a decreased risk of pregnancy loss, but may experience other pregnancy-related adverse outcomes.

Sign Up for Free e-Newsletters